Effect of long-term low-dose prednisone on height velocity and disease activity in pediatric and adolescent patients with Crohn disease

Journal of Pediatric Gastroenterology and Nutrition

Volumn 45, Issue 3, 2007, Pages 312-318

  Navarro, Fernando A ^a,b   Hanauer, Stephen B ^a   Kirschner, Barbara S ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Disease activity; Growth; Prednisone

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; AZATHIOPRINE; INFLIXIMAB; MERCAPTOPURINE; METHOTREXATE; PREDNISONE;

ADOLESCENT; ARTICLE; BODY HEIGHT; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; DRUG EFFECT; DRUG WITHDRAWAL; FEMALE; GROWTH RATE; HUMAN; LONG TERM CARE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PEDIATRICS; PRIORITY JOURNAL; REMISSION; SCHOOL CHILD; TREATMENT DURATION;

6-MERCAPTOPURINE; ADOLESCENT; AGE FACTORS; ANTI-INFLAMMATORY AGENTS; AZATHIOPRINE; CHILD; CROHN DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; GROWTH; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; PREDNISONE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 34548686811     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e31805b82c6     Document Type: Article

References (30)

1. Allen DB. Growth suppression by glucocorticoid therapy. Endocrinol Metab Clin N Am 1996;25:699-718.
2. Issenman RM. Bone mineral metabolism in pediatric inflammatory bowel disease. Inflamm Bowel Dis 1999;5:192-9.
3. Markowitz JGK, Rosa J, Aiges H, et al. Growth failure in paediatric patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1993;16:373-80.
4. Verhoeven AC. Limited bone loss due to corticosteroids: a systematic review of prospective studies in rheumatoid arthritis and other diseases. J Rheumatol 1997;24:1495-503.
5. Otley A, Loonen H, Parekh N, et al. Assessing activity of pediatric Crohn's disease: which index to use? Gastroenterology 1999;116: 527-31.
6. Blodgett FM, Burgin L, Iezzoni D, et al. Effects of prolonged cortisone therapy on the statural growth, skeletal maturation and metabolic status of children. N Engl J Med 1956;254: 636-41.
7. Cuttler L, Rosenfield RL. Somatic growth and maturation. In: DeGeroot LJ, Jameson JL, DeKretser D (eds). Endocrinology et al., 5th ed. Philadelphia: Elsevier; 2005: 697-732.
8. Tanner JM, Davies PS. Clinical longitudinal standards for height and height velocity for North American children. J Pediatr 1985;107:317-29.
9. Motil KJ, Grand RJ, Davis-Kraft L, et al. Growth failure in children with inflammatory bowel disease: a prospective study. Gastroenterology 1993;105:681-91.
10. Kanof ME, Lake AM, Bayless TM. Decreased height velocity in children and adolescents before the diagnosis of Crohn's disease. Gastroenterology 1988;95:1523-7.
11. Savage MO, Beattie RM, Camacho-Hubner C, et al. Growth in Crohn's disease. Acta Paediatr Suppl 1999;88:89-92.
12. Kirschner BS. Growth and development in chronic inflammatory bowel disease. Acta Paediatr Scand Suppl 1990;366:98-104.
13. Markowitz J, Grancher K, Rosa J, et al. Growth failure in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1993;16:373-80.
14. Griffiths AM, Nguyen P, Smith C, et al. Growth and clinical course of children with Crohn's disease. Gut 1993;34:939-43.
15. Plefferkom MD, Hyams J, Burke G, et al. Growth failure persists despite current treatment: paradigms in pediatric Crohn's disease. Gastroenterology 2006;130:S1271.
16. Harpaval M, Dang Q. Longitudinal effect of corticosteroids in pediatric Crohn's disease. Gastroenterology 2006;130:S1279.
17. Caldwell JR, Furst DE. The efficacy and safety of low-dose corticosteroids for rheumatoid arthritis. Semin Arthritis Rheum 1991;21:1-11.
18. Michels H. What is low-dose corticosteroid therapy in juvenile idiopathic arthritis? A worldwide, questionnaire-based survey. Z Rheumatol 2000;59:127-30.
19. Markowitz J, Grancher K, Kohn N, et al. A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease. Gastroenterology 2000;119:895-902.
20. Saha MT, Ruuska T, Laippala P, et al. Growth of prepubertal children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1998;26:310-4.
21. Kirschner BS, Sutton MM. Somatomedin-C levels in growth-impaired children and adolescents with chronic inflammatory bowel disease. Gastroenterology 1986;91:830-6.
22. Thomas AG, Holly JM, Taylor F, et al. Insulin like growth factor-I, insulin like growth factor binding protein-1, and insulin in childhood Crohn's disease. Gut 1993;34:944-7.
23. Beattie RM, Camacho-Hubner C, Wacharasindhu S, et al. Responsiveness of IGF-I and IGFBP-3 to therapeutic intervention in children and adolescents with Crohn's disease. Clin Endocrinol (Oxf) 1998;49:483-9.
24. Corkins MR, Gohil AD, Fitzgerald JF. The insulin-like growth factor axis in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2003;36:228-34.
25. Bannerjee K, Camacho-Hubner C, Babinska K, et al. Anti-inflammatory and growth-stimulating effects precede nutritional restitution during enteral feeding in Crohn disease. J Pediatr Gastroenterol Nutr 2004;38:270-5.
26. Chong SK, Grossman A, Walker-Smith JA, et al. Endocrine dysfunction in children with Crohn's disease. J Pediatr Gastroenterol Nutr 1984;3:529-34.
27. Touati GPA, Ruis JC, Noel M, et al. Beneficial effects of one year growth hormone administration to children with juvenile chronic arthritis on chronic steroid therapy. Effects on growth velocity and body composition. J Clin Endocrinol Metab 1998;83:403-9.
28. Jux CLK, Hugel U, Blum W, et al. Dexamethasone impairs growth hormone (GH)-stimulated growth suppression of local insulin-like growth factor (IGF)-I production and expression of GH and IGF-I receptor in cultured rat chondrocytes. Endocrinology 1998;139: 3296-305.
29. Malchow H, Ewe K, Brandes JW, et al. European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment. Gastroenterology 1984;86:249-66.
30. Goldstein ES, Marion JF, Present DH. 6-Mercaptopurine is effective in Crohn's disease without concomitant steroids. Inflamm Bowel Dis 2004;10:79-84.